1. Search Result
Search Result
Results for "

PRL

" in MedChemExpress (MCE) Product Catalog:

23

Inhibitors & Agonists

1

Biochemical Assay Reagents

3

Peptides

25

Recombinant Proteins

1

Isotope-Labeled Compounds

6

Antibodies

3

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-112476
    PRL-3 Inhibitor I
    1 Publications Verification

    Phosphatase Cancer
    PRL-3 Inhibitor I is a potent PRL-3 inhibitor with an IC50 of 0.9 μM. PRL-3 Inhibitor I shows a reduced invasion in cell-based assay .
    PRL-3 Inhibitor I
  • HY-103079

    Phosphatase Cancer
    PRL-3 Inhibitor 2 (compound 2) is a potent PRL-3 inhibitor with an IC50 value of 28.1 µM .
    PRL-3 Inhibitor 2
  • HY-P4452

    Somatostatin Receptor Urotensin Receptor Endocrinology
    PRL 2915 is a potent human somatostatin subtype 2 receptor (hsst2) antagonist with a Ki of 12 nM .
    PRL 2915
  • HY-W043170

    Phosphatase Cancer
    PRL3-CNNM4 PPI IN 1 (Compound C28d52) is an inhibitor of the PRL3-CNNM4 interaction and also inhibits PRL-mediated suppression of CNNM. PRL3-CNNM4 PPI IN 1 is capable of penetrating epithelial cell layers, exhibits metabolic stability, possesses favorable pharmacokinetic and pharmacodynamic properties, and holds potential for drug development based on this compound .
    PRL3-CNNM4 interaction-IN-1
  • HY-162119

    Phosphatase Cancer
    PRL-IN-1 (compound 43) is a phosphatase of regenerating liver (PRL) inhibitor that directly binds the PRL1 trimer interface and obstructs PRL1 trimerization. PRL-IN-1 shows potent anticancer activities .
    PRL-IN-1
  • HY-13976A

    Drug Derivative Neurological Disease
    PRL-8-53 is a derivative of 2-PhenylethylaMine. PRL-8-53 is an orally active psychotropic agent .
    PRL-8-53
  • HY-171035

    Quinone Reductase Keap1-Nrf2 Aminotransferases (Transaminases) Metabolic Disease
    PRL-295 is an orally active inhibitor targeting Keap1-Nrf2 interaction. PRL-295 increases the thermal stability of Keap1 and disrupts its interaction with Nrf2, thereby activating the Nrf2-dependent transcriptional target NAD(P)H:quinone oxidoreductase 1 (NQO1). PRL-295 protects against Acetaminophen (HY-66005)-induced liver injury in mice .
    PRL-295
  • HY-P4469

    Somatostatin Receptor Urotensin Receptor Cardiovascular Disease
    PRL 3195 is a somatostatin receptor antagonist with Kis of 6, 17, 66, 1000 and 1000 nM for human somatostatin receptors (sst5, sst2, sst3, sst1 and sst4, respectively) .
    PRL 3195
  • HY-RS11160

    Small Interfering RNA (siRNA) Others

    PRL Human Pre-designed siRNA Set A contains three designed siRNAs for PRL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    PRL Human Pre-designed siRNA Set A
    PRL Human Pre-designed siRNA Set A
  • HY-RS16777

    Small Interfering RNA (siRNA) Others

    Prl Mouse Pre-designed siRNA Set A contains three designed siRNAs for Prl gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Prl Mouse Pre-designed siRNA Set A
    Prl Mouse Pre-designed siRNA Set A
  • HY-RS23217

    Small Interfering RNA (siRNA) Others

    Prl Rat Pre-designed siRNA Set A contains three designed siRNAs for Prl gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Prl Rat Pre-designed siRNA Set A
    Prl Rat Pre-designed siRNA Set A
  • HY-128153
    Thienopyridone
    1 Publications Verification

    Phosphatase Apoptosis Cancer
    Thienopyridone is a potent and selective phosphatase of regenerating liver (PRL) phosphatase inhibitor with IC50s of 173 nM, 277 nM and 128 nM for PRL-1, PRL-2, and PRL-3, respectively. Thienopyridone shows minimal effects on other phosphatases. Thienopyridone induces p130Cas cleavage and apoptosis and has anticancer effects .
    Thienopyridone
  • HY-131547

    10-Ethenyl-19-norprogesterone

    Progesterone Receptor p38 MAPK Endocrinology
    Org OD 02-0 (10-Ethenyl-19-norprogesterone) is a membrane progesterone receptor α (mPRα)-specific agonist (IC50: 33.9 nM). Org OD 02-0 activates MAPK activity. Org OD 02-0 inhibits prolactin (PRL) secretion in the pituitary .
    Org OD 02-0
  • HY-114877

    Phosphatase Cancer
    CG-707 inhibits phosphatase of regenerating liver-3 (PRL-3) enzymatic activity with an IC50 value of 0.8 μM. CG-707 inhibits the migration and invasion of PRL-3 overexpressing colon cancer cells .
    CG-707
  • HY-P4523

    Endogenous Metabolite Endocrinology
    FA-Ala-Arg is a dipeptide with furylacryloyl group. FA-Ala-Arg breaks down to produce arginine. While cell-surface Carboxypeptidase-D (CPD) also increases intracellular Arg, which is converted to nitric oxide (NO). FA-Ala-Arg enhances NO production in MCF-7 cells. FA-Ala-Arg also increases the cell survival of prolactin (PRL)-treated cells, PRL regulates CPD mRNA levels in cells .
    FA-Ala-Arg
  • HY-NP198

    Biochemical Assay Reagents Endocrinology
    Human prolactin is a four-α-helix bundle protein hormone secreted by the anterior pituitary gland. The biological activities of Prolactin are mediated by its binding to the PRL receptor (PRLR) in a one-to-two complex and regulated by tertiary structural properties .
    Human prolactin
  • HY-B0537A

    MP-601205 dihydrochloride

    Parasite Fungal Phosphatase Bacterial Antibiotic Infection Cancer
    Pentamidine dihydrochloride (MP-601205 dihydrochloride) is an antimicrobial agent and interferes with DNA biosynthetics. Pentamidine dihydrochloride inhibits parasite Leishmania infantum with an IC50 of 2.5 μM. Pentamidine dihydrochloride is a potent and selective protein tyrosine phosphatases (PTPases) and phosphatase of regenerating liver (PRL) inhibitor. Pentamidine dihydrochloride has the potential for Gambian trypanosomiasis, antimony-resistant leishmaniasis, and Pneumocystis carinii pneumonia treatment. Antitumor and antibacterial activities .
    Pentamidine dihydrochloride
  • HY-B0537
    Pentamidine
    Maximum Cited Publications
    8 Publications Verification

    MP-601205

    Parasite Fungal Phosphatase Bacterial Antibiotic Infection Cancer
    Pentamidine (MP-601205) is an antimicrobial agent and interferes with DNA biosynthetics. Pentamidine inhibits parasite Leishmania infantum with an IC50 of 2.5 μM. Pentamidine is a potent and selective protein tyrosine phosphatases (PTPases) and phosphatase of regenerating liver (PRL) inhibitor. Pentamidine has the potential for Gambian trypanosomiasis, antimony-resistant leishmaniasis, and Pneumocystis carinii pneumonia treatment. Antitumor and antibacterial activities .
    Pentamidine
  • HY-B0537C

    MP-601205 dimesylate

    Antibiotic Parasite Fungal Phosphatase Bacterial Infection Cancer
    Pentamidine (MP-601205) dimesylate is an antimicrobial agent and interferes with DNA biosynthetics. Pentamidine dimesylate inhibits parasite Leishmania infantum with an IC50 of 2.5 μM. Pentamidine dimesylate is a potent and selective protein tyrosine phosphatases (PTPases) and phosphatase of regenerating liver (PRL) inhibitor. Pentamidine dimesylate has the potential for Gambian trypanosomiasis, antimony-resistant leishmaniasis, and Pneumocystis carinii pneumonia treatment. Antitumor and antibacterial activities .
    Pentamidine dimesylate
  • HY-B0537B
    Pentamidine isethionate
    Maximum Cited Publications
    8 Publications Verification

    MP-601205 isethionate

    Parasite Fungal Phosphatase Bacterial Antibiotic Infection Cancer
    Pentamidine isethionate (MP-601205 isethionate) is an antimicrobial agent and interferes with DNA biosynthetics. Pentamidine isethionate inhibits parasite Leishmania infantum with an IC50 of 2.5 μM. Pentamidine isethionate is a potent and selective protein tyrosine phosphatases (PTPases) and phosphatase of regenerating liver (PRL) inhibitor. Pentamidine isethionate has the potential for Gambian trypanosomiasis, antimony-resistant leishmaniasis, and Pneumocystis carinii pneumonia treatment. Antitumor and antibacterial activities .
    Pentamidine isethionate
  • HY-B0537R

    MP-601205 (Standard)

    Reference Standards Parasite Fungal Phosphatase Bacterial Antibiotic Infection Cancer
    Pentamidine (Standard) is the analytical standard of Pentamidine. This product is intended for research and analytical applications. Pentamidine (MP-601205) is an antimicrobial agent and interferes with DNA biosynthetics. Pentamidine inhibits parasite Leishmania infantum with an IC50 of 2.5 μM. Pentamidine is a potent and selective protein tyrosine phosphatases (PTPases) and phosphatase of regenerating liver (PRL) inhibitor. Pentamidine has the potential for Gambian trypanosomiasis, antimony-resistant leishmaniasis, and Pneumocystis carinii pneumonia treatment. Antitumor and antibacterial activities .
    Pentamidine (Standard)
  • HY-B0537AS

    MP-601205-d4(dihydrochloride)

    Isotope-Labeled Compounds Parasite Fungal Phosphatase Bacterial Antibiotic Infection Cancer
    Pentamidine-d4 (dihydrochloride) is the deuterium labeled Pentamidine dihydrochloride. Pentamidine dihydrochloride (MP-601205 dihydrochloride) is an antimicrobial agent and interferes with DNA biosynthetics. Pentamidine dihydrochloride inhibits parasite Leishmania infantum with an IC50 of 2.5 μM. Pentamidine dihydrochloride is a potent and selective protein tyrosine phosphatases (PTPases) and phosphatase of regenerating liver (PRL) inhibitor. Pentamidine dihydrochloride has the potential for Gambian trypanosomiasis, antimony-resistant leishmaniasis, and Pneumocystis carinii pneumonia treatment. Antitumor and antibacterial activities .
    Pentamidine-d4 dihydrochloride
  • HY-B0537BR

    MP-601205 isethionate (Standard)

    Reference Standards Parasite Fungal Phosphatase Bacterial Antibiotic Infection Cancer
    Pentamidine (isethionate) (Standard) is the analytical standard of Pentamidine (isethionate). This product is intended for research and analytical applications. Pentamidine isethionate (MP-601205 isethionate) is an antimicrobial agent and interferes with DNA biosynthetics. Pentamidine isethionate inhibits parasite Leishmania infantum with an IC50 of 2.5 μM. Pentamidine isethionate is a potent and selective protein tyrosine phosphatases (PTPases) and phosphatase of regenerating liver (PRL) inhibitor. Pentamidine isethionate has the potential for Gambian trypanosomiasis, antimony-resistant leishmaniasis, and Pneumocystis carinii pneumonia treatment. Antitumor and antibacterial activities .
    Pentamidine isethionate (Standard)

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: